london euretina

Instructional Courses

Buy courses during registration or login to your account
if you have already registered

  • Thursday 17 September

  • IC 0
  • Uveitis Course

    C. Pavesio UK C. Herbort SWITZERLAND

    Abstract    Schedule

  • Update on Posterior Uveitis

    Thalie (Level 3)

    Course Outline:

    1 - Diagnosis
    2 - Work-up and investigational procedures
    3 - Main entities
    4 - Treatment
    5 - Complications

      08:45 – 10:30
      Diagnosis, work-up and investigational procedures

    • 08.45
    • M. Khairallah TUNISIA

      Introduction: Clinical assessment of posterior uveitis

    • 09.10
    • A. Denniston UK

      Investigational work-up of posterior uveitis

    • 09.30
    • C. P. Herbort SWITZERLAND Download Handout

      Angiographic work-up for posterior uveitis

    • 10.00
    • P. Neri ITALY

      OCT in posterior uveitis

    • 10:30

    • Discussion

    • 10:40

    • Coffee Break

      11:00 – 12:15
      II. Main Entities - IIa. Infectious

    • 11.00
    • C. Pavésio UK Download Handout


    • 11.18
    • A. El Asrar SAUDI ARABIA Download Handout


    • 11.36
    • M. Stanford UK

      Viral Retinitis

    • 11.54
    • P. Kestelyn BELGIUM


    • 12:12

    • Discussion

      12:15 – 13:00
      IIb1. Non-infectious

    • 12.15
    • A.El Asrar SAUDI ARABIA Download Handout


    • 12.35
    • C. P. Herbort SWITZERLAND Download Handout

      Choriocapillaritis – MEWDS
      Multifocal Choroiditis

    • 13:00

    • Discussion

    • 13:10

    • Lunch Break

      14:10 – 15:40
      IIb2. Non-infectious

    • 14.10
    • M. Westcott UK

      Serpiginous Choroidopathy

    • 14.25
    • A. Abu El-Asrar SAUDI ARABIA

      Stromal choroiditis I: VKH &SO

    • 14.40
    • C. Pavesio UK Download Handout

      Stromal choroiditis II: Birdshot

    • 14.55
    • N. Jones UK Download Handout


    • 15.10
    • P. LeHoang FRANCE Download Handout


    • 15:40

    • Discussion

    • 15:50

    • Coffee Break

      16:10 – 18:20
      III. Treatment, complications & surgery

    • 16.10
    • C. Pavesio UK Download Handout

      Local therapies in posterior uveitis

    • 16.26
    • M. Khairallah TUNISIA

      Steroids and Immunosuppressives

    • 16.42
    • A. Denniston UK


    • 16:58

    • Discussion

      17.00 - 18.10
      IV. Complications & Surgery

    • 17.00
    • M. Stanford UK


    • 17.15
    • N. Jones UKDownload Handout


    • 17.35
    • P. LeHoang FRANCE


    • 17.55
    • P. Sullivan UK

      Vitreoretinal Surgery

    • 18:10

    • Discussion

  • 0

  • Thursday 17 September

  • IC 0
  • Retinal Detachment Course

    I. Kreissig Germany

    Abstract    Schedule

    • 8:30
    • I. Kreissig GERMANY

    • 8:30
    • I. Kreissig GERMANY
      F. LaFranco USA


    • 1.1. B. Aylward UK
      Lattice degeneration and breaks in fellow eye: What to do or not to do?


    • 2.1. I. Kreissig GERMANY
      The 4 Rules to find the primary break

    • 2.2. U. Mester GERMANY
      A detachment without a break: What to try first?


    • 3.1. I. Kreissig GERMANY
      A look at cerclage after 50 years: Indications, complications, long-term results


    • S. Yamamoto JAPAN, G. Richard GERMANY

    • 4.1. F. LaFranco USA
      Indications, optimal tamponade of break(s), video of surgery: complications, long-term anatomic and functional results

    • 4.2. U. Vossmerbaeumer GERMANY
      Differential diagnosis of residual fluid


    • 5.1. I. Kreissig GERMANY
      Application, indications, video of surgery, complications, long-term anatomic and functional results

    • 10:50

    • 11:10
      B. Aylward UK, S. Mennel GERMANY

    • 6.1. P. Stanga UK
      Pneumatic retinopexy for uncomplicated detachments


    • 7.1. S. Mennel AUSTRIA
      Rationale, indications, complications, long-term results

    • 7.2. S. Yamamoto JAPAN
      Comparison of 20-, 23-, 25-gauge ppv: Indications, complications, results


    • 8.1. I. Kreissig GERMANY
      Reoperation: The 4 Rules to find the undetected break

    • 8.2. G. Richard GERMANY
      How to minimize risk of PVR

    • 8.3. J. Schmidt GERMANY
      PVR-C1/C2 detachments. Try buckling first: Long-term anatomic and functional results

    • 12:40

    • 13:00

    • 14:00
      J. SchmidtGERMANY, P Stanga UK

    • 9.1. A. Sudhalkar INDIA
      Classification of diabetic retinopathy

    • 9.2. M. Engelbert USA
      Laser coagulation: When to do?

    • 9.3 A. Kothari INDIA
      Intravitreal pharmacotherapy :When to do?


    • 10.1.
    • T. Boeker GERMANY
      Temporary balloon buckle vs. pneumatic retinopexy vs. segmental buckling vs. primary vitrectomy

    • 11. VARIOUS

    • 11.1. V. Ferrara ITALY
      Misdiagnosis of retinoschisis

    • 11.2 N. Sivkova BULGARIA
      Ambulatory double patching

      I. Kreissig GERMANY Organizer: T. Boeker GERMANY
      B. Aylward, V. Ferrara, A. Kothari, F. LaFranco, S. Mennel, U. Mester, G. Richard, J. Schmidt, N. Sivkova, P. Stanga A. Sudhalkar, U. Vossmerbaeumer, S. Wolf, S. Yamamoto


  • Thursday 17 September

  • IC 1
  • wetlab prerequisite
    Proliferative Vitreoretinopathy, Surgical Management and Improved Techniques

    J.G. Arumi SPAIN

    Abstract    Schedule

  • Course

    Organiser: J. García Arumi SPAIN

    Cost: €25

    • 08.30
    • V. Martinez-Castillo SPAIN
      Management of thelens in PVR

    • 08.40
    • B.CorCost: egui SPAIN
      Scleral band and vitrectomy in PVR

    • 08.50
    • J. García Arumi SPAIN
      PFCL and trypan blue in the membrane disection

    • 09.00
    • R. Tadayoni FRANCE
      PVR from concept to surgical progress

    • 09.10
    • T. Wolfensberger SWITZERLAND

    • 09.20
    • S. Rizzo ITALY
      Endotamponades in PVR

    • 09.30

    • Clinical cases with discussion

    • 10.00

    • End of course

  • Title:: Proliferative vitreoretinopathy, surgical management and improved techniques

    Audience Level: Intermediate/advanced

    Proliferative vitreoretinopathy (PVR) is the clinical syndrome associated with
    retinal traction and detachment in which proliferative cells multiply and
    contract on retinal surfaces and in the vitreous.
    PVR is the most common cause of failure in retinal detachment surgery. Therefore,prevention through early recognition of risk factors and subtle signs of PVR and appropriate modification of standard surgical techniques for retinal detachment
    remain all important.
    In this course we will describe the pathophysiology, main risk factors, and the vitreoretinal surgery of PVR, with the need or not of scleral buckling, lensectomy associated to vitrectomy in PVR, the surgical steps, the dissection of the proliferative tissue using PFCL and different stainings to improve the identification, and dissection of the membranes, the indications and technique of relaxing retinotomy and the endotamponade.

    Following attendance of this course the attendee will be able to understand the process of PVR, the surgical techniques employed and the prognostic factors of success.

  • IC 2
  • wetlab prerequisite
    Controversies in Laser Therapy in Retinal Disease, Including Indications & Procedures

    A. Loewenstein ISRAEL E. Midena xxxx ITALY

    Abstract    Schedule

  • Course Organisers: A. Loewenstein COUNRTY, R. Tadayoni COUNTRY

    Cost: €25

    • Debate 1

    • 08.30
    • G. Soubrane FRANCE
      Macular laser is still important in DME as primary or deferred therapy

    • 08.35
    • S. Michels SWITZERLAND
      No more room for macular laser in DME either as primary or deferred therapy

    • 08.40
    • Discussion

    • Debate 2

    • 08.50
    • M. deSmet BELGIUM
      Laser to the periphery is needed in persistent DME

    • 08.55
    • B. Eldem TURKEY
      No room for peripheral laser in DME

    • 09.00
    • Discussion

    • Debate 3

    • 09.10

    • E. Midena ITALY
      Subthreshold laser is the future

    • 09.15
    • A. Augustin GERMANY
      No proof for subthreshold laser

    • 09.20
    • Discussion

    • Debate 4

    • 09.30
    • A. Koh SINGAPORE
      PDT is still crucial in selected cases of AMD (eg- polypilidal)

    • 09.35
    • P. Lanzetta ITALY
      No more room for laser in AMD

    • 09.40
    • Discussion

    • 09.50
    • P. Udaondo SPAIN
      Case presentation showing importance of laser therapy

    • 10.00

    • End of course

  • Title:: Laser Therapy in Retinal Disease: Indications & Procedures

    Audience Level: Retina specialists

    Background: Laser therapy has been a gold standard in the history of treating retinal diseases such as age-related macular degeneration, retinal vein occlusion, and diabetic retinopathy. Through the years, developments of new drugs and technologies have changed the role of laser therapy. Recent innovations to laser have continued to refine its precision, reducing risks, and increasing its importance as a key treatment.

    Course Objective This course aims to discuss the current role of laser therapy in retina practice today. At the conclusion of this course, attendees will be able to distinguish among indications and procedures of laser therapy.

  • IC 3
  • wetlab prerequisite
    Key Issues for SD-OCT Interpretation and OCT- Angio interpretation

    A. Gaudric FRANCE G.   Staurenghi ITALY A.   Tufail UK

    Abstract    Schedule

  • Course Organisers: A. Gaudric France, G. Staurenghi Italy, A. Tufail UK

    Cost: €25

    • 08.30
    • G. Staurenghi Italy,
      A. Invernizzi Italy

    • 1.
    • Basics of OCT and OCT A interpretation, new nomenclature
      A. The normal retina
      - Retinal and choroidal layers
      - Retinal and choroidal circulation viewed by OCT Angio
      B.OCT Interpretation
      - Drusen
      - Retinal and choroidal atrophy

    • 09.00
    • A. Tufail UK,
      P. Keane UK

    • 2.
    • Neovascular age macular degeneration
      - Early diagnosis of CNV
      - Vascularized an avascular PED
      Retinal angiomatous proliferation
      - Classification of CNV
      - OCT assessment of CNV treatment

    • 09.30
    • A. Gaudric France,
      S. Mrejen France

    • 3.
    • Vitreo-macular diseases, macular œdema, central serous chorioretinopathy
      - Normal vitreo-macular interface
      - Vitreo-macular adhesion and traction: new classification
      - Aspects of macular œdema and cystoid maculopathies
      - Chronic and atypical CSC

    • 10.00

    • End of course

  • Background:
    The increasing improvements in OCT devices allow obtainingdetailed OCT images according to various modalities (B scan, en face OCT, OCT Angio).The analysis of OCT images should integrate all recent advancesin the interpretation of the main pathological changes characterizing macular diseases.

    Course objective(s):
    Understanding the main functions of the most popular SD-OCT devices, including segmentation and en-face images. Being able to detect all the retinal and choroidal layers on OCT. Knowing the OCT characteristics related to the main signs of macular diseases such as drusen, choroidal newvessels, pigment epithelium detachment, polypoidalchoroidal vasculopathy, sub-retinal fluid, cystoid macular edema, retinal ischemia, vitreo-macular traction… At the end of this course, the attendeesshould have improved their ability to diagnose the main macular diseases on OCT.

    A. Differences between the main SD-OCT devices, including OCT Angio and impact on the examination strategy
    B. Normal OCT B-scan of the Macula: new nomenclature. Normal OCT Angio.
    D. Signs of macular diseases on OCT
    - Vitreo-macular adhesion/vitreo-macular traction, early PVD,new OCT classification.
    - Epiretinal membranes and macular pseudo-holes
    - Macular holes, measurement of the hole diameter
    - Macular edema, andmacular cystic cavities of various etiologies
    - Drusen, Geographic atrophy
    - Choroidal new vessels
    - Pigment epithelium detachment
    - Polypoidal choroidal vasculopathy
    - Retinal angiomatous proliferation
    - Central serous chorioretinopathy, subretinal fluid and deposits

    Targeted audience and level:
    Retina specialists / Intermediate/ Advanced Level

    Alain Gaudric (Paris)
    Alessandro Invernizzi(Milano)
    Sarah Mrejen (Paris)
    Pearse Keane (London)
    Giovanni Staurenghi (Milano)
    Adnan Tufail(London)

    Not for website:

  • Thursday 17 September

  • IC 5
  • wetlab prerequisite
    Submacular Haemorrhages in AMD: A Practical Guide to Management

    D.   Steel UK

    Abstract    Schedule

  • Course Leader:
    D. Steel UK

    Cost: €25

    • 11.00
    • D. Steel UK


    • 11.02
    • G. McGowan UK

      Epidemiology, mechanisms of visual loss, risk factors and classfn.

    • 11.15
    • Z. Koshy UK

      Clinical assessment: How to decide what to do – observation, anti VEGFs alone or surgery?

    • 11.28
    • J. van Meurs NETHERLANDS

      Pneumatic displacement - how to do it.

    • 11.41
    • J. Hillenkamp GERMANY

      Vitrectomy and subretinal TPA/anti VEGF - how to do it.

    • 11.54
    • D. Yorston UK

      Results, complications and limitations - How do the two techniques compare?

    • 12.07
    • D. Steel UK

      Too big to displace? What else can be tried

    • 12. 20

    • Discussion

    • 12.30

    • End of course

  • Title:: Submacular haemorrhages in AMD: a practical guide to management

    Course Leader:
    David Steel

    Audience Level: Retinal specialists

    Level: Intermediate

    Format Options:
    A proposal for a didactic course at Euretina Nice 2015 - with scheduled questions and answers managed by the course organiser.

    Course Description:Submacular haemorrhage (SMH) presenting in patients with neovascular age-related macular degeneration (nAMD), when left untreated, is associated with a poor visual prognosis. Risk factors for its occurrence are ill defined and the exact incidence of SMH in patients with AMD is uncertain. Patients with significant SMH were excluded from all the recent major randomised control trials for nAMD and the optimum management is uncertain. The location, size, thickness and duration of SMH have an important bearing on treatment and outcomes. Thin or extrafoveal SMH may be best treated with anti VEGF agents alone. Thicker subfoveal blood can be displaced away from the foveal centre either by means of an expansile gas injection combined with intravitreal TPA or with vitrectomy, subretinal TPA injection and air or gas exchange. Anti VEGF agents can be used concomitantly either intravitreally or subretinally. Both approaches have their pros and cons which will be discussed. More invasive techniques may have a role in selected severe cases.
    This course will summarise what is known about SMH in nAMD and discuss a variety of therapeutic interventions including practical skills and techniques.

    Further reading:
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacularhemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.Graefes Arch ClinExpOphthalmol.2010 ;248(1):5-11.

    vanZeeburg EJ, van Meurs JC. Literature review of recombinant tissue plasminogen activator used for recent-onset submacularhemorrhage displacement in age-related macular degeneration.Ophthalmologica. 2013;229(1):1-14.

    Steel DH, Sandhu SS. Submacular haemorrhages associated with neovascular
    age-related macular degeneration. Br J Ophthalmol. 2011 Aug;95(8):1051-7.

    Course Objectives:
    At the end of the course it is expected that the attendees will be able to:
    1) Understand the epidemiology and characteristics of SMH in AMD including mechanisms of visual loss if untreated , risk factors for occurrence , classification, and clinical assessment
    2) Define which patients benefits from anti VEGF treatment alone
    3) Describe the range of SMH displacement techniques available for SMH- including which technique to choose in which situation and optimising visual results.
    4) Discuss the surgical techniques themselves so that they have a clear knowledge of the surgical steps involved
    5) Discuss what options are available for massive haemorrhages

    Conclusion: A comprehensive knowledge of the causes, pathophysiology and management of submacular haemorrhages associated with AMD

  • IC 6
  • wetlab prerequisite
    The Vitreoretinal Interface- Physiology, Pathology and Treatment

    C.   Haritoglou GERMANY

    Abstract    Schedule

  • Chairperson: C. Haritoglo GERMANY

    Cost: €25

    • 11.00
    • R. Tadayoni FRANCE

      Imaging at the vitreoretinal interface: Classifications and predictive aspects

    • 11.20
    • R. Schumann GERMANY

      Clinicopathological correlations at the vitreoretinal interface

    • 11.40
    • A. Gandorfer GERMANY

      Treatment of VRI-diseases: Surgery and enzymatic vitreolysis

    • 12.00
    • C. Haritoglou GERMANY

      Pathophysiology of the vitreoretinal interface

    • 12.20

    • Discussion

    • 12.30

    • End of course

  • The vitreoretinal interface – physiology, pathology and treatment

    This course gives an overview over the physiology of the vireoretinal interface and it's pathophysiological role in the pathogenesis of various conditions such as tractive maculopathies (macular hole, epimacular membranes, macular pseudoholes and lamellar holes etc) and other macular dieseases. We aim to establish a clinical correlation with modern high resolution imaging modalities such as OCT and other macular functional diagnostic tools such as microperimetry. We will discuss several disease entities with regard to (differential) diagnostic and predictive aspects of therapeutic strategies and will present relevant clinico-morphologic correlations. Also, the role and potential impact of new therapeutic measures such as enzymatic vitreolysis on the vitreoretinal interface will be discussed.

  • IC 7
  • wetlab prerequisite
    Macular Traction & Macular Hole in High Myopic Eyes: Diagnosis & Treatment Options

    G.   Pertile ITALY

    Abstract    Schedule

  • Chairperson: G. Pertile ITALY

    Cost: €25

    • 11.00
    • G. Pertile ITALY


    • 11.05
    • F. Bottoni ITALY

      Physiopathology and healing process in idiopathic macular

    • 11.20
    • A.Polito ITALY

      Physiopathology of macular traction in high myopic eyes

    • 11.35
    • G. Prigione ITALY

      Vitrectomy and inverted ILM flap technique for macular hole: How does it work?

    • 11.50
    • A. Alfano ITALY

      Vitrectomy with inverted flap technique versus complete ILM removal: Anatomic and functional outcome

    • 12.05
    • M. Mete ITALY

      Pro’s and con’s of macular buckling

    • 12.20

    • Discussion

    • 12.30

    • End of course

  • 0

  • IC 8
  • wetlab prerequisite
    Subthreshold Laser Surgery-Advantages & Disadvantages of Micropulse& Other Subthreshold Laser Techniques


    Abstract    Schedule

  • Course Organisers:

    Jan Keunen NETHERLANDS

    Camiel Boon NETHERLANDS

    V. Chong UK

    E. Midena ITALY

    Jeff Luttrull USA

    Cost: €25

    • 11.00
    • J. Keunen NETHERLANDS

      Introduction and recent developments in subthreshold laser surgery

    • 11.10
    • V. Chong UK

      Basic principles of micropulse laser and differences to other subthreshold laser techniques

    • 11.25
    • E. Midena ITALY

      Subthresholdmicropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation in DME

    • 11.40
    • J.Luttrull USA

      Safety of transfovealsubthreshold diode micropulse laser for DME in eyes with good visual acuity

    • 11.55

      The PLACE trial: subthresholdmicropulse laser treatment versus PDT in chronic central serous chorioretinopathy (PLACCE trial)

    • 12.10

    • Case Presentations, followed by active discussion of the panel with the audience

    • Discussion

    • 12.30

    • End of course

  • Title:: Subthreshold Laser Surgery
    Advantages and disadvantages of micropulse and other subthreshold laser techniques

    Course Leader and Organisers :
    J. Keunen NETHERLANDS (course leader)

    Audience Level: Beginners, Intermediate & Advanced level Retina Specialists (including Residents with posterior segment laser experience).

    5 Didactic presentations with scheduled questions and answers, managed by the course leader;
    Followed by case presentations and active discussions between the audience and panelists.

    Abstract and outline
    ABSTRACT. Subthreshold tissue-sparing laser therapy is worldwide a subject of growing interest for retina specialists. Micropulse diode laser therapy is currently the most frequent used subthreshold laser technique, producing a therapeutic treatment effect without detectable intraretinal damage on clinical examination during or after treatment (even on autofluorescence and SD-OCT). The controlled delivery of laser micropulses affords excellent treatment options for diabetic macular edema (DME), central serous chorioretinopathy (CSR), macular edema secondary to branch retinal vein occlusion (BRVO), and glaucoma.
    This course will explain the micropulse technology and focus on the benefits and challenges in the treatment of retinal disorders using a micropulse diode laser. It has been shown to be as effective as conventional argon laser for DME (see the suggested readings) without reported complications or collateral effects so far.
    However, treating below the ophthalmoscopically visible endpoint raises the question of the optimum laser dose. The most serious disadvantage seems undertreatment. Therefore, the development of optimal laser settings will be discussed in order to minimize the clinical concern of nonresponders. Retreatment is easily feasible, as micropulse treatment does not produce chorioretinal scars or carry an increased risk of CNV.

    OUTLINE. Different subthreshold techniques will be discussed, and their tissue effects. Micropulse diode laser settings and safety issues will be presented, the optimum indications, doubts after treatment (how long wait for a treatment response?) and retreatment indications discussed. A possible future for combined micropulse and anti-VEGF treatment strategies resulting in lesser injections for DME will be discussed, followed by clinical cases with an interactive discussion of the panel with the audience.

    1. Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF, Cunha-Vaz JG, Chong NV.
    Prospective randomized controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol. 2009;93(10):1341-1344.
    2. Vujosevic S, Bottega E, Casciano M,Pilotto E, Convento E, Midena E. Microperimetry and fundus auto fluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina. 2010;30(6):908-916.
    3. Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina. 2012 Feb;32(2):375-86.
    4. Luttrull JK, Sinclair SH. Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity. Retina. 2014 Oct;34(10):2010-20.

    Course Objectives: The aim of the course is to provide retinal specialists with an up-to-date overview of the clinical significance of subthreshold laser surgery, with a focus on micropulse diode laser treatment.
    The expected outcome for participants is that they will better understand the basics of tissue-sparing laser surgery, recognise the optimum treatment indications and will be able to perform micropulse laser surgery safely in their own practice.

    Conclusion: Participants will gain from the course a full understanding of the key differences between conventional and subthreshold laser surgery techniques and will recognize the advantages and disadvantages of tissue sparing laser treatment.

  • Thursday 17 September

  • IC 9
  • wetlab prerequisite
    ABC in Effective Ophthalmic Publishing

    A.   Grzybowski POLAND

    Abstract    Schedule

  • Chairperson: A.Grzybowski POLAND

    Cost: €25

    • 14.00
    • E. Stefansson ICELAND

      Essentials of a good article

    • 14.15
    • F. Bandello ITALY

      Costs of Evidence-Based-Medicine, multicentre trials and independence of research

    • 14.30
    • A. Loewenstein ISRAEL

      The challenge of publishing case reports

    • 14.45
    • J. Cunha-Vaz PORTUGAL

      What means revision and how should the revision be prepared?

    • 15.00
    • A. Grzybowski POLAND

      Ethical aspects of publishing

    • 15.15

    • Discussion

    • 15.30

    • End of course

  • Title:: ABC in effective ophthalmic publishing

    Course Leader:
    A. Grzybowski, Professor of Ophthalmology, Poznan, Olsztyn, Poland

    Audience Level: Comprehensive ophthalmologists/ Basic

    Format Options: Didactic presentations with scheduled questions and answers managed by the course director

    Abstract and outline
    Fast development of computer technology and internet changed the publication practice over last decade. The need for speed and global availability of publication has become now at least equally important as the prestige of a journal. In this course we emphasize the basics of modern scientific publishing looking more closely on the manuscript traffic within the editorial office and
    the manuscript selection. In this light we indicate good authors habits which dramatically speeds up the publication process. We also take a look at two other major problems, such as ethical problems, and understanding the role of citations and journals impact factor in building up scientific career.
    At the conclusion of this course the attendee will be able to describe the essentials of a good article, how to deal with reviewers comments and how to prepare the revision, how to prepare the good case report article, and characterize some aspects of multicentre trials and ethics in publishing.

    Suggested readings:
    1. Stefánsson E, Kivelä T. The ingredients of a good paper. Acta Ophthalmol. 2010;88:619-21.
    2. Grzybowski A. The journal impact factor: how to interpret its true value and importance. Med Sci Monit. 2009;15(2):SR1-4.
    3. Grzybowski A. Impact factor – benefits and limitations. Acta Ophthalmologica 2015
    5. Liesegang TJ, Bartley GB. Toward Transparency of Financial Disclosure. American Journal
    of Ophthalmology 2014; 158: 855–857.
    5. Bartley GB, Albert DM, Liesegang TJ. Choosing Our Words Carefully: Plagiarism in the Internet Age. Ophthalmology 2014; 121: 807–808.

    Course Description: In this course we emphasize the basics of modern scientific publishing, including the structure of an original and review article, case report and letter to the editor. We will instruct how to prepare a good revision. .
    Course Objectives:
    To discuss basics of a good article
    To discuss differences among different sort of articles, original, review, case reports and letter to the editor;
    To discuss basic of ethical issues in publishing

    Conclusion: Participants will be able to describe the essentials of a good article, how to deal with reviewers comments and how to prepare the revision, how to prepare the good case report article, and characterize some aspects of multicentre trials and ethics in publishing.

  • IC 10
  • wetlab prerequisite
    Management of Recurrent Rhegmatogenous Retinal Detachment

    M.   Elgohary UK

    Abstract    Schedule

  • Course

    Organiser: M. Elgohary UK

    Cost: €25

    • 14.00
    • M. Elgohary UK
      Introduction, general principles and causes of recurrent RD

    • 14.10
    • S. Harsum UK
      Getting it right with scleral buckle

    • 14.25
    • S. Harsum UK
      Management of recurrent RD after scleral buckling

    • 14.40
    • M. Elgohary UK
      Getting it right with vitrectomy

    • 14.55
    • M. Elgohary UK
      Management of recurrent RD after vitrectomy

    • 15.10
    • S. Harsum, M. Elgohary UK
      Case Discussion

    • 15.30

    • End of course

  • Title::
    Management of recurrent retinal detachment course outline

    Didactic presentations with scheduled questions and answers managed by the course director.

    Target audience and level:
    Retina specialists

    Abstract and outline :
    Background: Despite the evolving technical advances in retinal detachment (RD) surgery, the recurrence rate still ranges between 10% to 20%, making it the most common complication of retinal detachment surgery.
    This course will provide an overview of the different causes, preventative strategies, and management options of recurrent RD.
    At the conclusion of this course the attendee will be: (1) able to describe the possible causes and risk factors for recurrent RD, (2) Be familiar with the principles and technical details of pneumatic retinopexy, scleral buckling and vitrectomy procedures that would reduce the risk of recurrence of RD, and (3) Be able to understand the different surgical techniques for the management of recurrent RD including revision of the scleral buckles, combining scleral buckling and vitrectomy, performing retinectomy and the use of different tamponading agents.

  • IC 11
  • wetlab prerequisite
    Management of Proliferative Diabetic Retinopathy

    A.   Laidlaw UK M.   Mohamed UK

    Abstract    Schedule

  • Course Organisers: A. Laidlaw UK, M. Mohamed UK

    Cost: €25

    • 14.00
    • A. Laidlaw UK
      Welcome and introduction

    • 14.10
    • L. Downey UK
      Pathophysiology of PDR

    • 14.20
    • S. Mann UK
      Epidemiology, classification and screening for PDR

    • 14.30
    • M. Mohamed UK
      PRP, when to start, where to do it, how much to do, when to stop

    • 14.40
    • S. Mann UK
      Addressing general medical risk factors

    • 14.50
    • A. Laidlaw UK
      Role of antiVEGF drugs: Current and future, anterior hyaloid proliferation and rubeosis

    • 15.00
    • T. Williamson UK
      Diabetic vitreous haemorrhage: Aetiology and management

    • 15.10
    • D. Steel UK
      Retinal traction from PDR: Aetiology and management

    • 15.20

    • Discussion

    • 15.30

    • End of course

  • Course Leader Mr DAH Laidlaw/Mr Moin Mohamed

    Audience Level: Retina specialists/Comprehensive ophthalmologists/ Beginner / Intermediate /

    Format Options:

    Didactic presentations with scheduled questions and answers managed by the course director

    Abstract and outline

    Course Objectives and Conclusion: This course will provide participants with a practical pragmatic understanding of the basis and management of Proliferative Diabetic Retinopathy.

    Course Description:

    We will cover the biochemical basis of the condition, description of the treated and untreated natural history of the condition, the importance of general medical management of diabetes , hypertension and lipids and screening for retinopathy; a description of treatment thresholds and a guide to how to do a PRP and anti VEGF treatment , and a discussion of the role of vitrectomy in the management .

  • IC 12
  • wetlab prerequisite
    Stem cell-based therapies in retinal disease - Fundamentals and Application

    A. Pollreisz AUSTRIA

    Abstract    Schedule

  • Course Leader:
    Andreas Pollreisz AUSTRIA

    Cost: €25

    • 14.00
    • Y. Chen AUSTRIA

      General introduction to stem cells

    • 14.20
    • R. Grillari AUSTRIA

      Methods of retinal stem cell isolation and generation

    • 14.40
    • A. Pollreisz AUSTRIA

      Retinal stem cell therapy – application and results from clinical studies

    • 15.00
    • K. Balaggan UK

      Future perspectives for retinal stem cells

    • 15.15

    • Questions from audience

    • 15.30

    • End of course

  • Title::
    Stem cell-based therapies in retinal disease - Fundamentals and Application

    Course Leader:

    Andreas Pollreisz

    Audience Level:
    Comprehensive ophthalmologists/ Retina specialists / Beginner/Intermediate

    Format Options:
    Didactic presentations with scheduled questions and answers managed by the course director

    This course aims to provide the clinician with a basic introduction to stem cells, as well as profound background information on ways of isolation and application of retinal stem cells through didactic presentations.
    Topics that will be discussed in depth include a general introduction to stem cells, approaches of how to isolate stem cells, results from clinical studies and perspectives for future use in the field of retinal therapy.
    At the conclusion of this educational session, the attendee will be able to understand fundamental basics and be up-to date with latest clinical study results of stem cell-based retinal treatment modalities.

EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy